The war of words between pharmaceutical giant AstraZeneca and the European Commission continued on Thursday after a crisis meeting the previous evening failed to resolve the row over vaccine supplies.
AstraZeneca told the European Commission last week there would be a 60% shortfall in supplies this quarter due to production problems. Both sides described talks held on Wednesday as “constructive”, but they failed to heal the rift.
Belgian health authorities said on Thursday they had inspected a pharmaceutical factory to find out whether expected delays in the deliveries of AstraZeneca’s coronavirus vaccine were due to production issues, as the company has claimed.
To read the full article from Euronews, please click here